vvtv

Medivation, Inc. (Nasdaq: MDVN) 114.3% HIGHER; the company and partner Astellas Pharma said the Independent Data Monitoring Committee informed them of positive results from a planned interim analysis of the Phase 3 AFFIRM trial of MDV3100 in men with advanced prostate cancer.

MDV3100 successfully met the study's pre-specified interim efficacy stopping criteria, demonstrating a clinically meaningful and statistically significant (p < 0.0001) improvement in overall survival compared to placebo.

ValueVision Media, Inc.

Valuevision Media, Inc. (Nasdaq: VVTV) 28.5% LOWER; reported Q2 loss of ($0.09), 3 cents worse than the analyst estimate of ($0.06).

Revenue for the quarter came in at $132.14 million versus the consensus estimate of $143.39 million. Internet Sales increased 23% with e-commerce penetration up 670 bps to 46.1%.

Vanceinfo Technologies Inc. ADS (NYSE: VIT) 28.0% LOWER; reported Q2 EPS of $0.21, 2 cents worse than the analyst estimate of $0.23.

Revenue for the quarter came in at $68.2 million versus the consensus estimate of $67.51 million.

The Trading Radar highlights key earnings and economic announcements for tomorrow's trading session: Before Market Opens: Economics: 8:30am EST

• Housing Starts - Street Sees 600K
• Building Permits - Street Sees 580K
• CPI - Street Sees 0.2%

Earnings: BJ's Wholesale Club (NYSE: BJ) – consensus EPS $0.45 012 Smile Communications Inc.

(NASDAQ: SMLC) – no consensus Chico's FAS, Inc. (NYSE: CHS) – consensus EPS $0.07 Gushan Environmental Energy Ltd.